Skip to main content
. 2015 Dec 29;11(3):1005–1010. doi: 10.3892/etm.2015.2958

Figure 4.

Figure 4.

Immunohistochemical staining of CD34+ microvessels in the different treatment groups. (A) CD34+ microvessels in the ischemic hemisphere (magnification, ×400). (B) CD34+ microvessels in the sham, vehicle and rolipram-treated groups at different time-points; the rolipram-treated group showed a significantly higher number of CD34+ microvessels than the vehicle and sham groups (#P<0.01), and the rolipram group with longer treatment duration exhibited a higher number of CD34+ microvessels ($P<0.05). CD34, cluster of differentiation 34.